183 related articles for article (PubMed ID: 20481176)
61. Heat-related toxicity with the fentanyl transdermal patch.
Newshan G
J Pain Symptom Manage; 1998 Nov; 16(5):277-8. PubMed ID: 9846020
[No Abstract] [Full Text] [Related]
62. Transdermal fentanyl for pain relief in a paediatric palliative care population.
Hunt A; Goldman A; Devine T; Phillips M;
Palliat Med; 2001 Sep; 15(5):405-12. PubMed ID: 11591092
[TBL] [Abstract][Full Text] [Related]
63. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
64. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
[TBL] [Abstract][Full Text] [Related]
65. [Transdermal fentanyl for the management of cancer pain: a survey of 4492 patients].
Yu SY; Sun Y; Wu YL; Qin SK; Xie GR; Liu SJ; Sui GJ; Zhang HC
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):369-72. PubMed ID: 16117902
[TBL] [Abstract][Full Text] [Related]
66. Ketamine Infusion as a Counter Measure for Opioid Tolerance in Mechanically Ventilated Children: A Pilot Study.
Neunhoeffer F; Hanser A; Esslinger M; Icheva V; Kumpf M; Gerbig I; Hofbeck M; Michel J
Paediatr Drugs; 2017 Jun; 19(3):259-265. PubMed ID: 28299720
[TBL] [Abstract][Full Text] [Related]
67. Postsurgery analgesic and sedative drug use in a French neonatal intensive care unit: A single-center retrospective cohort study.
Benahmed-Canat A; Plaisant F; Riche B; Rabilloud M; Canat G; Paret N; Claris O; Kassai B; Nguyen KA
Arch Pediatr; 2019 Apr; 26(3):145-150. PubMed ID: 30885601
[TBL] [Abstract][Full Text] [Related]
68. Remifentanil-induced tolerance, withdrawal or hyperalgesia in infants: a randomized controlled trial. RAPIP trial: remifentanil-based analgesia and sedation of paediatric intensive care patients.
Welzing L; Link F; Junghaenel S; Oberthuer A; Harnischmacher U; Stuetzer H; Roth B
Neonatology; 2013; 104(1):34-41. PubMed ID: 23635551
[TBL] [Abstract][Full Text] [Related]
69. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients.
Cammarano WB; Pittet JF; Weitz S; Schlobohm RM; Marks JD
Crit Care Med; 1998 Apr; 26(4):676-84. PubMed ID: 9559604
[TBL] [Abstract][Full Text] [Related]
70. Methadone conversion in infants and children: Retrospective cohort study of 199 pediatric inpatients.
Fife A; Postier A; Flood A; Friedrichsdorf SJ
J Opioid Manag; 2016; 12(2):123-30. PubMed ID: 27194197
[TBL] [Abstract][Full Text] [Related]
71. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
Mercadante S; Ferrera P; Adile C; Casuccio A
J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
[TBL] [Abstract][Full Text] [Related]
72. A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain.
Kornick CA; Santiago-Palma J; Schulman G; O'Brien PC; Weigand S; Payne R; Manfredi PL
Cancer; 2003 Jun; 97(12):3121-4. PubMed ID: 12784350
[TBL] [Abstract][Full Text] [Related]
73. Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain.
Mercadante S; Villari P; Ferrera P; Casuccio A; Mangione S; Intravaia G
Br J Cancer; 2007 Jun; 96(12):1828-33. PubMed ID: 17519902
[TBL] [Abstract][Full Text] [Related]
74. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
[TBL] [Abstract][Full Text] [Related]
75. The Opioid Rotation Ratio From Transdermal Fentanyl to "Strong" Opioids in Patients With Cancer Pain.
Reddy A; Yennurajalingam S; Reddy S; Wu J; Liu D; Dev R; Bruera E
J Pain Symptom Manage; 2016 Jun; 51(6):1040-5. PubMed ID: 26826675
[TBL] [Abstract][Full Text] [Related]
76. Fentanyl buccal tablet.
Messina J; Darwish M; Fine PG
Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
[TBL] [Abstract][Full Text] [Related]
77. A patient-activated iontophoretic transdermal system for acute pain management with fentanyl hydrochloride: overview and applications.
Bain KT
J Opioid Manag; 2006; 2(6):314-24. PubMed ID: 17326593
[TBL] [Abstract][Full Text] [Related]
78. Iontophoretic drug delivery system: focus on fentanyl.
Herndon CM
Pharmacotherapy; 2007 May; 27(5):745-54. PubMed ID: 17461710
[TBL] [Abstract][Full Text] [Related]
79. Intramuscular Fentanyl and Ketorolac Associated with Superior Pain Control After Pediatric Bilateral Myringotomy and Tube Placement Surgery: A Retrospective Cohort Study.
Stricker PA; Muhly WT; Jantzen EC; Li Y; Jawad AF; Long AS; Polansky M; Cook-Sather SD
Anesth Analg; 2017 Jan; 124(1):245-253. PubMed ID: 27861435
[TBL] [Abstract][Full Text] [Related]
80. A new once-a-day fentanyl citrate patch (Fentos Tape) could be a new treatment option in patients with end-of-dose failure using a 72-h transdermal fentanyl matrix patch.
Koike K; Terui T; Nagasako T; Horiuchi I; Machino T; Kusakabe T; Hirayama Y; Mihara H; Yamakage M; Kato J; Nishisato T; Ishitani K
Support Care Cancer; 2016 Mar; 24(3):1053-9. PubMed ID: 26248654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
